Title | Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Mahajan A, Spracklen CN, Zhang W, et al. |
Corporate Authors | FinnGen, eMERGE Consortium |
Journal | Nat Genet |
Volume | 54 |
Issue | 5 |
Pagination | 560-572 |
Date Published | 2022 05 |
ISSN | 1546-1718 |
Keywords | Diabetes Mellitus, Type 2, Ethnicity, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Polymorphism, Single Nucleotide, Risk Factors |
Abstract | We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the Diabetes Meta-Analysis of Trans-Ethnic association studies (DIAMANTE) Consortium. Multi-ancestry GWAS meta-analysis identified 237 loci attaining stringent genome-wide significance (P < 5 × 10), which were delineated to 338 distinct association signals. Fine-mapping of these signals was enhanced by the increased sample size and expanded population diversity of the multi-ancestry meta-analysis, which localized 54.4% of T2D associations to a single variant with >50% posterior probability. This improved fine-mapping enabled systematic assessment of candidate causal genes and molecular mechanisms through which T2D associations are mediated, laying the foundations for functional investigations. Multi-ancestry genetic risk scores enhanced transferability of T2D prediction across diverse populations. Our study provides a step toward more effective clinical translation of T2D GWAS to improve global health for all, irrespective of genetic background. |
DOI | 10.1038/s41588-022-01058-3 |
Alternate Journal | Nat Genet |
PubMed ID | 35551307 |
PubMed Central ID | PMC9179018 |
Grant List | R01 DK078616 / DK / NIDDK NIH HHS / United States 086113 / WT_ / Wellcome Trust / United Kingdom 064890 / WT_ / Wellcome Trust / United Kingdom 200837 / WT_ / Wellcome Trust / United Kingdom R01 HL142302 / HL / NHLBI NIH HHS / United States 220457 / WT_ / Wellcome Trust / United Kingdom 098381 / WT_ / Wellcome Trust / United Kingdom U01 DK078616 / DK / NIDDK NIH HHS / United States 090367 / WT_ / Wellcome Trust / United Kingdom UM1 DK078616 / DK / NIDDK NIH HHS / United States 203141 / WT_ / Wellcome Trust / United Kingdom 084723 / WT_ / Wellcome Trust / United Kingdom R01 DK039311 / DK / NIDDK NIH HHS / United States U01 DK085545 / DK / NIDDK NIH HHS / United States 088158 / WT_ / Wellcome Trust / United Kingdom 101630 / WT_ / Wellcome Trust / United Kingdom 090532 / WT_ / Wellcome Trust / United Kingdom K99 AG066849 / AG / NIA NIH HHS / United States 206194 / WT_ / Wellcome Trust / United Kingdom 212284 / WT_ / Wellcome Trust / United Kingdom R01 DK098032 / DK / NIDDK NIH HHS / United States 212946 / WT_ / Wellcome Trust / United Kingdom 202922 / WT_ / Wellcome Trust / United Kingdom 072960 / WT_ / Wellcome Trust / United Kingdom 104085 / WT_ / Wellcome Trust / United Kingdom R01 HL105756 / HL / NHLBI NIH HHS / United States U01 DK105535 / DK / NIDDK NIH HHS / United States 101033 / WT_ / Wellcome Trust / United Kingdom 083948 / WT_ / Wellcome Trust / United Kingdom 098051 / WT_ / Wellcome Trust / United Kingdom 212259 / WT_ / Wellcome Trust / United Kingdom 085475 / WT_ / Wellcome Trust / United Kingdom 200186 / WT_ / Wellcome Trust / United Kingdom R01 DK090111 / DK / NIDDK NIH HHS / United States 095101 / WT_ / Wellcome Trust / United Kingdom 106130 / WT_ / Wellcome Trust / United Kingdom 098017 / WT_ / Wellcome Trust / United Kingdom 098395 / WT_ / Wellcome Trust / United Kingdom |